🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Health care providers and organizations! A new toolkit from research_her has guidance on how to incorporate a beverage screener into your electronic health record. #ChildHealth #SugaryDrinks bit.ly/48qQRYQ

Last month was the one-year anniversary of the White House Conference & National Strategy on Hunger, Nutrition & Health. FDA continues to make great progress on our nutrition efforts. I’d like to catch up with you today about important, new developments. fda.gov/news-events/fd…

Medicaid Expansion is possible because of people like Penny. She was brave enough to get out and tell her story, and because of her, hundreds of thousands of working North Carolinians will now get health care.

Game changers: do new medications make lifestyle‐based treatment of obesity obsolete? - Kristina Lewis Jamy D. Ard onlinelibrary.wiley.com/doi/10.1002/ob…

Hooray! 🥳Our team can't wait to get to work on using the EHR to connect eligible pregnant patients with WIC! Right, Kimberly Montez, MD, MPH, FAAP ?

We just updated our The BMJ review of the long term outcomes of metabolic/bariatric surgery in adults - the evidence for long-term impact has increased significantly since our last review - Anita Courcoulas @CRDaigleMD bmj.com/content/383/bm…

Our study is out nature. We identify non-lipid risk pathways for coronary artery disease using pooled CRISPR-interference for 2,285 genes at GWAS loci. With an amazing team we identified the genetic risk pathways for CAD that act in endothelial cells. nature.com/articles/s4158…

Read the #ObesityJournal perspective article "Game changers: do new medications make lifestyle‐based treatment of obesity obsolete?" Kristina Lewis Jamy D. Ard onlinelibrary.wiley.com/doi/10.1002/ob…

"It’s about access and equity." New obesity medications like #Ozempic are trending in the media, but what about older, generic options like phentermine? Learn more about Kristina Lewis and Jamy D. Ard and their #LEAP research: bit.ly/3Tg18Bm

Says Sarah Ro, MD, #GLP1orBust is a lame way to think about #ObesityCare. Daniel Engber reminds us that people can get half the effect of #Ozempic for 1/30th of the expense. Nope, obesity medicine wasn't born yesterday. 1/2 conscienhealth.org/2024/03/obesit…

To open #OMA2024 yesterday, David Arterburn, MD, MPH presented a brilliant perspective on the radical paradigm shift and price wars that lie ahead in #obesity care. conscienhealth.org/2024/04/can-ob…

Editorial: Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists ja.ma/44L7M74 #ECO2024

The latest from Annals is online now. Find out about antidepressants and weight gain, the effect of #acupuncture on #methadone reduction, and CER of apixaban, rivaroxaban, and warfarin in patients with cirrhosis and AF: ecs.page.link/9AYn6

I don't often post professional updates, but I'm pretty proud of this one. I am so thankful to our amazing Dean, Dr. Ebony Boulware, for the opportunity and humbled to be in the company of the stellar scientists in this inaugural group 🙏🌟

The current BAR for GLP1 indication in U.S. is TOO LOW. GLP1 is a powerful drug and many in the Weight Management bucket without serious comorbidities do not need this drug. There are older oral agents that are available and affordable NOW for lower risk groups! And they work!

Coming Out Against the Healthy Lifestyle sensible-med.com/p/coming-out-a…

Pableaux Johnson, the Heart of New Orleans Hospitality, Dies at 59 — beautiful obituary: nytimes.com/2025/01/28/din…

Hmm. There are two errors in this, and also the new 15% limit is way too low. And finally this is an unintentional call for communism. (1) First error. This charge isn’t for “overhead”. It does include overhead, but it also includes “General & Administrative” costs. For

Many large state universities across US have indirect rates that are similar. The impact of this, which will dramatically decrease investment in biomedical research, will be felt in nearly all states. As described, this likely represents a nearly 10% cut to the NIH budget.

Imagine what would happen today if @doge posted on @x there was a study “testing the venom of Gila monsters to determine if they can cure diabetes “. globalnews.ca/news/9793403/o…